论文部分内容阅读
目的:观察小儿肺热咳喘口服液辅助治疗小儿急性社区获得性肺炎(CAP)的疗效及毒副作用。方法:儿科门诊或住院确诊的小儿 CAP 180例,随机分为治疗组120例,对照组60例,两组均进行常规抗感染治疗,治疗组加用小儿肺热咳喘口服液,对照组用异丙嗪止咳糖浆。结果:治疗组总有效率90.8%,对照组70%(P<0.01),有统计学差异;在退热、止咳、消除啰音方面治疗组均优于对照组(P 均<0.01),未见明显不良反应。结论:小儿肺热咳喘口服液辅助治疗社区获得性肺炎疗效好,无毒副作用。
Objective: To observe the curative effect and toxic side effects of Xiaoerfehenkechuan oral liquid in the treatment of pediatric acute community-acquired pneumonia (CAP). Methods: One hundred and eighty children with pediatric outpatient or hospitalized children were randomly divided into treatment group (n = 120) and control group (n = 60). Both groups were given conventional anti-infective therapy. Promethazine Cough Syrup. Results: The total effective rate was 90.8% in the treatment group and 70% in the control group (P <0.01), with statistical significance. The treatment group was superior to the control group in the aspects of fever, cough relief and elimination of rales (P <0.01) See obvious adverse reactions. Conclusion: Pediatric Feiregan Kechuan oral liquid adjuvant treatment of community-acquired pneumonia with good efficacy, no toxic side effects.